Cargando…
Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
BACKGROUND: Focal adhesion kinase (FAK) autophosphorylation seems to be a potential therapeutic target but little is known about the role and prognostic value of FAK and pFAK in epithelial ovarian cancer (EOC). Recently, we validated a gene signature classifying EOC patients into two subclasses and...
Autores principales: | Aust, Stefanie, Auer, Katharina, Bachmayr-Heyda, Anna, Denkert, Carsten, Sehouli, Jalid, Braicu, Ioana, Mahner, Sven, Lambrechts, Sandrina, Vergote, Ignace, Grimm, Christoph, Horvat, Reinhard, Castillo-Tong, Dan Cacsire, Zeillinger, Robert, Pils, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998046/ https://www.ncbi.nlm.nih.gov/pubmed/24655477 http://dx.doi.org/10.1186/1476-4598-13-67 |
Ejemplares similares
-
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013) -
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2012) -
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014) -
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
por: Trillsch, Fabian, et al.
Publicado: (2013) -
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)